These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 31933519)

  • 21. Comprehensive investigation of key biomarkers and pathways in hepatitis B virus-related hepatocellular carcinoma.
    Liao X; Yu T; Yang C; Huang K; Wang X; Han C; Huang R; Liu X; Yu L; Zhu G; Su H; Qin W; Deng J; Zeng X; Han B; Han Q; Liu Z; Zhou X; Liu J; Gong Y; Liu Z; Huang J; Lu L; Ye X; Peng T
    J Cancer; 2019; 10(23):5689-5704. PubMed ID: 31737106
    [No Abstract]   [Full Text] [Related]  

  • 22. Fermentable fiber-induced hepatocellular carcinoma in mice recapitulates gene signatures found in human liver cancer.
    Chandrashekar DS; Golonka RM; Yeoh BS; Gonzalez DJ; Heikenwälder M; Gerwirtz AT; Varambally S; Vijay-Kumar M
    PLoS One; 2020; 15(6):e0234726. PubMed ID: 32559205
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical and prognostic value of chaperonin containing T-complex 1 subunit 3 in hepatocellular carcinoma: A Study based on microarray and RNA-sequencing with 4272 cases.
    Hou JY; Wu HY; He RQ; Lin P; Dang YW; Chen G
    Pathol Res Pract; 2019 Jan; 215(1):177-194. PubMed ID: 30473171
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.
    Liang L; Gao L; Zou XP; Huang ML; Chen G; Li JJ; Cai XY
    Mol Med Rep; 2018 Feb; 17(2):2297-2312. PubMed ID: 29207053
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Identification of Hepatocellular Carcinoma-Related Potential Genes and Pathways Through Bioinformatic-Based Analyses.
    Wan Z; Zhang X; Luo Y; Zhao B
    Genet Test Mol Biomarkers; 2019 Nov; 23(11):766-777. PubMed ID: 31633428
    [No Abstract]   [Full Text] [Related]  

  • 26. Identification of key genes and pathways by bioinformatics analysis with TCGA RNA sequencing data in hepatocellular carcinoma.
    Zhu Q; Sun Y; Zhou Q; He Q; Qian H
    Mol Clin Oncol; 2018 Dec; 9(6):597-606. PubMed ID: 30546887
    [TBL] [Abstract][Full Text] [Related]  

  • 27. RRAD inhibits aerobic glycolysis, invasion, and migration and is associated with poor prognosis in hepatocellular carcinoma.
    Shang R; Wang J; Sun W; Dai B; Ruan B; Zhang Z; Yang X; Gao Y; Qu S; Lv X; Tao K; Wang L; Dou K; Wang D
    Tumour Biol; 2016 Apr; 37(4):5097-105. PubMed ID: 26546438
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tumor-adjacent tissue co-expression profile analysis reveals pro-oncogenic ribosomal gene signature for prognosis of resectable hepatocellular carcinoma.
    Grinchuk OV; Yenamandra SP; Iyer R; Singh M; Lee HK; Lim KH; Chow PK; Kuznetsov VA
    Mol Oncol; 2018 Jan; 12(1):89-113. PubMed ID: 29117471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NAT10 is upregulated in hepatocellular carcinoma and enhances mutant p53 activity.
    Li Q; Liu X; Jin K; Lu M; Zhang C; Du X; Xing B
    BMC Cancer; 2017 Aug; 17(1):605. PubMed ID: 28859621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of a five-long non-coding RNA signature to improve the prognosis prediction for patients with hepatocellular carcinoma.
    Zhao QJ; Zhang J; Xu L; Liu FF
    World J Gastroenterol; 2018 Aug; 24(30):3426-3439. PubMed ID: 30122881
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Tumor-suppressor p53 gene in hepatitis C and B virus-associated human hepatocellular carcinoma.
    Shieh YS; Nguyen C; Vocal MV; Chu HW
    Int J Cancer; 1993 Jun; 54(4):558-62. PubMed ID: 8390407
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Expression and clinical significance of TAp73alpha, p53, PCNA and apoptosis in hepatocellular carcinoma.
    Qin HX; Nan KJ; Yang G; Jing Z; Ruan ZP; Li CL; Xu R; Guo H; Sui CG; Wei YC
    World J Gastroenterol; 2005 May; 11(18):2709-13. PubMed ID: 15884108
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Upregulation of CENPM promotes hepatocarcinogenesis through mutiple mechanisms.
    Xiao Y; Najeeb RM; Ma D; Yang K; Zhong Q; Liu Q
    J Exp Clin Cancer Res; 2019 Nov; 38(1):458. PubMed ID: 31703591
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Expression profiles and prognostic significance of RNA N6-methyladenosine-related genes in patients with hepatocellular carcinoma: evidence from independent datasets.
    Zhou Y; Yin Z; Hou B; Yu M; Chen R; Jin H; Jian Z
    Cancer Manag Res; 2019; 11():3921-3931. PubMed ID: 31118805
    [No Abstract]   [Full Text] [Related]  

  • 35. SKA1 overexpression is associated with poor prognosis in hepatocellular carcinoma.
    Chen Y; Zhao J; Jiao Z; Wang W; Wang D; Yu X; Shi Z; Ge N; Pan Q; Xia J; Niu W; Zhao R; Zhang X; Du W
    BMC Cancer; 2018 Dec; 18(1):1240. PubMed ID: 30537941
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Histological subtypes of hepatocellular carcinoma are related to gene mutations and molecular tumour classification.
    Calderaro J; Couchy G; Imbeaud S; Amaddeo G; Letouzé E; Blanc JF; Laurent C; Hajji Y; Azoulay D; Bioulac-Sage P; Nault JC; Zucman-Rossi J
    J Hepatol; 2017 Oct; 67(4):727-738. PubMed ID: 28532995
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hepatocellular carcinoma-associated single-nucleotide variants and deletions identified by the use of genome-wide high-throughput analysis of hepatitis B virus.
    Liu WC; Wu IC; Lee YC; Lin CP; Cheng JH; Lin YJ; Yen CJ; Cheng PN; Li PF; Cheng YT; Cheng PW; Sun KT; Yan SL; Lin JJ; Yang JC; Chang KC; Ho CH; Tseng VS; Chang BC; Wu JC; Chang TT
    J Pathol; 2017 Oct; 243(2):176-192. PubMed ID: 28696069
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identifying hub genes and dysregulated pathways in hepatocellular carcinoma.
    Jin B; Wang W; Du G; Huang GZ; Han LT; Tang ZY; Fan DG; Li J; Zhang SZ
    Eur Rev Med Pharmacol Sci; 2015 Feb; 19(4):592-601. PubMed ID: 25753876
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Critical genes of hepatocellular carcinoma revealed by network and module analysis of RNA-seq data.
    Yang MR; Zhang Y; Wu XX; Chen W
    Eur Rev Med Pharmacol Sci; 2016 Oct; 20(20):4248-4256. PubMed ID: 27831650
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comprehensive characterization of cancer genes in hepatocellular carcinoma genomes.
    Zhang Z; Xu L; Sun C
    Oncol Lett; 2018 Feb; 15(2):1503-1510. PubMed ID: 29434842
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.